本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Edgewise Therapeutics, Inc.

16.91
+0.23001.38%
盘后16.910.00000.00%16:40 EDT
成交量:142.87万
成交额:2,410.12万
市值:17.78亿
市盈率:-11.68
高:17.30
开:16.64
低:16.05
收:16.68
数据加载中...
2022/09/13

重要事件披露

8-K - Current report
2022/08/15

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/08/04

重要事件披露

8-K - Current report
2022/08/04

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/06/24

重要事件披露

8-K - Current report
2022/05/11

重要事件披露

8-K - Current report
2022/05/11

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/05/03

SEC问询函

CORRESP [Cover] - Correspondence
2022/02/24

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2022/02/24

重要事件披露

8-K - Current report
2022/02/24

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/01/13

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/01/13

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/01/05

重要事件披露

8-K - Current report
2021/12/01

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/11/17

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/11/12

持股变动声明

4 - Statement of changes in beneficial ownership of securities